Literature DB >> 8406154

Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.

Y Raab1, B Gerdin, S Ahlstedt, R Hällgren.   

Abstract

The concentration of myeloperoxidase, a neutrophil granule constituent, was measured in the perfusion fluid from sigmoid and rectal segments in patients with ulcerative colitis. The concentrations of myeloperoxidase were increased severalfold in the patients with ulcerative colitis compared with healthy controls pointing to an enhanced neutrophil activity. The release of myeloperoxidase correlated to an enhanced local release of the neutrophil activating peptide interleukin-8 (IL-8). Increased values of tumour necrosis factor (TNF-alpha) were also found during intestinal perfusion of the patients and correlated with those of IL-8. The results obtained are compatible with the hypothesis that local mucosal recruitment/activation of neutrophils in ulcerative colitis is mediated by an enhanced IL-8 synthesis. TNF-alpha may be one relevant factor as a stimulus to IL-8 synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406154      PMCID: PMC1375454          DOI: 10.1136/gut.34.9.1203

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor.

Authors:  I Lindley; H Aschauer; J M Seifert; C Lam; W Brunowsky; E Kownatzki; M Thelen; P Peveri; B Dewald; V von Tscharner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 2.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

3.  Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist.

Authors:  M Thelen; P Peveri; P Kernen; V von Tscharner; A Walz; M Baggiolini
Journal:  FASEB J       Date:  1988-08       Impact factor: 5.191

4.  Monokine-induced gene expression of a human endothelial cell-derived neutrophil chemotactic factor.

Authors:  R M Strieter; S L Kunkel; H J Showell; R M Marks
Journal:  Biochem Biophys Res Commun       Date:  1988-11-15       Impact factor: 3.575

5.  Presence of NAP-1/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis.

Authors:  P Peichl; M Ceska; F Effenberger; G Haberhauer; H Broell; I J Lindley
Journal:  Scand J Immunol       Date:  1991-09       Impact factor: 3.487

6.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

Authors:  J M Schröder; E Christophers
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts.

Authors:  R M Strieter; S H Phan; H J Showell; D G Remick; J P Lynch; M Genord; C Raiford; M Eskandari; R M Marks; S L Kunkel
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

9.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes.

Authors:  I Colditz; R Zwahlen; B Dewald; M Baggiolini
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  41 in total

1.  Eosinophil granulocytes are activated during the remission phase of ulcerative colitis.

Authors:  M Lampinen; A Rönnblom; K Amin; G Kristjansson; F Rorsman; P Sangfelt; B Säfsten; M Wagner; A Wanders; O Winqvist; M Carlson
Journal:  Gut       Date:  2005-05-10       Impact factor: 23.059

2.  Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis.

Authors:  Ying-Qiang Zhong; Hua-Rong Huang; Zhao-Hua Zhu; Qi-Kui Chen; Jun Zhan; Lian-Chun Xing
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

3.  Increased circulating concentrations of growth-related oncogene (GRO)-alpha in patients with inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Osamu Tsuruta; Nobuo Tomiyasu; Kosuke Takaki; Asuka Suzuki; Junya Masuda; Hiroshi Yamasaki; Atsushi Toyonaga; Michio Sata
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

4.  Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.

Authors:  M Carlson; Y Raab; L Sevéus; S Xu; R Hällgren; P Venge
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

5.  Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.

Authors:  Krishna P Reddy; Jonathan E Markowitz; Eduardo D Ruchelli; Robert N Baldassano; Kurt A Brown
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

6.  Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.

Authors:  Vanessa Mitsialis; Sarah Wall; Peng Liu; Jose Ordovas-Montanes; Tamar Parmet; Marko Vukovic; Dennis Spencer; Michael Field; Collin McCourt; Jessica Toothaker; Athos Bousvaros; Alex K Shalek; Leslie Kean; Bruce Horwitz; Jeffrey Goldsmith; George Tseng; Scott B Snapper; Liza Konnikova
Journal:  Gastroenterology       Date:  2020-05-16       Impact factor: 22.682

Review 7.  Chemokines in the inflammatory bowel diseases.

Authors:  R P MacDermott
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

8.  CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation.

Authors:  Yang Xu; Hongxia Dong; Changhui Ge; Yan Gao; Haifeng Liu; Weiguang Li; Chenggang Zhang
Journal:  Ann Transl Med       Date:  2016-08

9.  The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice.

Authors:  T Jakobsson; L-L Vedin; T Hassan; N Venteclef; D Greco; M D'Amato; E Treuter; J-Å Gustafsson; K R Steffensen
Journal:  Mucosal Immunol       Date:  2014-05-07       Impact factor: 7.313

10.  Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitis.

Authors:  Alexandra Zahn; Thomas Giese; Max Karner; Annika Braun; Ulf Hinz; Wolfgang Stremmel; Robert Ehehalt
Journal:  BMC Gastroenterol       Date:  2009-02-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.